Growth-promoting effect of recombinant human growth hormone and stanozolol in girls with Turner syndrome

Fang Junmin , Ning Cong , Shu Dan , Wei Hong , Lin Hanhua , Wang Mudi

Current Medical Science ›› 1999, Vol. 19 ›› Issue (1) : 63

PDF
Current Medical Science ›› 1999, Vol. 19 ›› Issue (1) : 63 DOI: 10.1007/BF02895600
Article

Growth-promoting effect of recombinant human growth hormone and stanozolol in girls with Turner syndrome

Author information +
History +
PDF

Abstract

Ten girls with Turner syndrome were treated with a combination therapy of recombinant human growth hormone (R-hGH) and low dose stanozolol for a period of 8 to 36 months. The results showed that when compared with the growth rate before the treatment, the growth rates after treatment with R-hGH and stanozolol showed a sustained increase, reaching 9. 0±l.9 cm/year during the first year of treatment; the height age increase by 2. 5±0.8 years while the bone age increase were 1. 0±0. 7 years; and the predicted final adult height at the end of the first year of the treatment increased to 149. 4±6. 1 cm compared to their original mean of 142. 8 ±4. 2 cm. We are led to conclude that therapy with R-hGH in combination with stanozolol can increase the growth velocity and significantly increase the predicted adult height of children with Turner syndrome.

Keywords

recombinant human growth hormone (R-hGH) / Turner syndrome / growth velocity / predicted adult height

Cite this article

Download citation ▾
Fang Junmin, Ning Cong, Shu Dan, Wei Hong, Lin Hanhua, Wang Mudi. Growth-promoting effect of recombinant human growth hormone and stanozolol in girls with Turner syndrome. Current Medical Science, 1999, 19(1): 63 DOI:10.1007/BF02895600

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

TakanoK, ShlzumeK, HibiI, et al. . Cross-sectional growth study in patients with Turner syndrome. Endocrinol Japan, 1988, 35(4631-631

[2]

BayleyN, PineauS. Tables for predicting adult height from skeletal age. J Pediatr, 1952, 14: 432-432

[3]

HeinrichsC, BourguignonJ P. Treatment of delayed puberty and hypogondism in girls. Horm Res, 1991, 36: 147-147

[4]

Turner, 1995, 13(6):378

[5]

TakanoKazue, ShizumeKazue, HibiItsuro, et al. . Turner syndrome: treatment of 203 patient with recombinant human growth hormone for one year. Acta Endocrinologica (Copenh), 1989, 120: 559-559

[6]

RosenfeldR G, FraneJ, AttieK M, et al. . Six-year results of a randomizied, prospective trial of human growth hormone and oxandrolone in Turner syndrom. J Pediatr, 1992, 121: 49-49

[7]

ZachmannM, SobradilloB, FrankM, et al. . Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height presictions in normal children and in patients with various pathologic conditions. J Pediatr, 1978, 98: 749-749

[8]

TakanoK, ShizumeK, HibiI, et al. . Long-term effects of growth hormone on height in Turner syndrome: Results of an 8-year multicentre study in Japan. Horm Res, 1995, 43: 141-141

AI Summary AI Mindmap
PDF

88

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/